OpenAI Researcher to Launch Drug Discovery Startup
TechCrunch AI · rss · 2026-07-15
TechCrunch AI reports that OpenAI researcher Miles Wang is raising funds for an AI drug discovery startup, targeting a valuation of around $2 billion.
The report also notes that Lightspeed is in talks to lead the funding round; however, negotiations are ongoing, making this an unconfirmed deal rumor.
More from Venture
- Anthropic's $80B 'loss' is mostly non-cash: $72.4B from convertible note revaluation — ChrisGPT · 2026-10-27
- McKinsey: Vertical AI Hits ROI in 6 Months 71% of the Time vs 32% for Horizontal Tools — MartinGTobias · 2026-10-27
- SendCutSend, born from a $750K impulse laser cutter buy, hits $2.1B valuation — kyliebytes · 2026-10-27
- After 20 Years of Launches, HN Shah Publishes His Early Access Playbook — AI_Andrew · 2026-10-27
- Cloudflare pilots Mastercard's Agent Payment for Machines with Coinbase wallets — kleffew94 · 2026-10-27
- Permissions are the moat: LetterBox wins Threads posting approval from Meta — rchardkovacs · 2026-10-27